Suppr超能文献

肝动脉灌注化疗和放射治疗对Fontan相关肝病所致肝细胞癌的显著疗效

Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.

作者信息

Suzuki Hiroyuki, Niizeki Takashi, Shirono Tomotake, Koteda Yusuke, Kinjyo Yoshinao, Mizukami Naohisa, Koda Makoto, Ota Satoshi, Nakano Masahito, Okamura Shusuke, Iwamoto Hideki, Shimose Shigeo, Noda Yu, Kamachi Naoki, Kajiwara Akira, Suda Kenji, Akiba Jun, Yano Hirohisa, Kuromatsu Ryoko, Koga Hironori, Torimura Takuji

机构信息

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan.

Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan.

出版信息

Intern Med. 2022 Apr 15;61(8):1145-1150. doi: 10.2169/internalmedicine.8154-21. Epub 2021 Sep 25.

Abstract

Fontan-associated liver disease (FALD) caused by long-term systemic venous congestion following the Fontan procedure may eventually lead to hepatocellular carcinoma (HCC). Treatment strategies for HCC due to FALD (FALD-HCC) remain unclear. We herein report a 35-year-old man with FALD-HCC that was well controlled by 3 cycles of continuous infusion of 5-fluorouracil and low-dose cisplatin (low-dose FP therapy) combined with 60 Gy of radiation therapy. However, the patient ultimately died of extrahepatic metastases. A pathological autopsy revealed more than 90% necrosis in the primary HCC lesion. This case suggests that low-dose FP therapy might be effective in FALD-HCC.

摘要

Fontan手术后继发的长期体静脉淤血所导致的Fontan相关肝病(FALD)最终可能会引发肝细胞癌(HCC)。FALD相关HCC(FALD-HCC)的治疗策略仍不明确。我们在此报告一名35岁患有FALD-HCC的男性患者,其通过3个周期的5-氟尿嘧啶持续输注和低剂量顺铂(低剂量FP疗法)联合60 Gy放射治疗得到了良好控制。然而,该患者最终死于肝外转移。病理尸检显示原发性HCC病灶坏死率超过90%。该病例提示低剂量FP疗法可能对FALD-HCC有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b5/9107970/c3c4dc7c36f2/1349-7235-61-1145-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验